Topotecan Hydrochloride Injection, Powder, Lyophilized, For Solution
Product Images NDC 63323-762

5 FDA label images from Fresenius Kabi Usa, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Topotecan Hydrochloride (NDC 63323-762). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Top0e 0005 01)

Structural Formula (Top0e 0005 01)
Chemical structure of Topotecan Hydrochloride, showing the molecular arrangement including aromatic rings, hydroxyl, methyl, and hydrochloride moieties as part of the compound's structure.*
FDA Label Image

Figure 1 (Top0e 0005 02)

Figure 1 (Top0e 0005 02)
A Kaplan-Meier survival curve chart comparing proportion surviving over months on study for Topotecan plus Cisplatin versus Cisplatin monotherapy. The solid line represents Topotecan plus Cisplatin, and the dotted line represents Cisplatin monotherapy, with survival declining over time up to 40 months. Below the graph is a table showing the number of patients at risk at various time points for both treatment groups.*
FDA Label Image

Logo (Top0e 0005 03)

FDA Label Image

Principal Display (Topotecan 4 mg Single Dose Vial Label)

Principal Display (Topotecan 4 mg Single Dose Vial Label)
Label for Topotecan Hydrochloride for Injection, USP 4 mg/4 mL single dose vial by Fresenius Kabi USA, LLC. The label states 4 mg base per vial, for intravenous use, must be diluted, and includes storage instructions and a caution for cytotoxic agent handling.*
FDA Label Image

Principal Display (Topotecan 4 mg Single Dose Vial Individual Carton)

Principal Display (Topotecan 4 mg Single Dose Vial Individual Carton)
Packaging label for Topotecan Hydrochloride for Injection, USP, 4 mg (base) per vial by Fresenius Kabi USA, LLC. The label includes usage instructions indicating intravenous use, requirement for dilution, and cytotoxic agent warnings. It also lists inactive ingredients, storage conditions, and a barcode with the NDC 63323-762-10. The label displays the manufacturer's logo and website.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.